These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3135831)

  • 1. Endocrine effects of 17 alpha-hydroxyprogesterone caproate during early pregnancy: a double-blind clinical trial.
    Reijnders FJ; Thomas CM; Doesburg WH; Rolland R; Eskes TK
    Br J Obstet Gynaecol; 1988 May; 95(5):462-8. PubMed ID: 3135831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of 17 alpha-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population.
    Hauth JC; Gilstrap LC; Brekken AL; Hauth JM
    Am J Obstet Gynecol; 1983 May; 146(2):187-90. PubMed ID: 6682631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.
    Manuck TA; Esplin MS; Biggio J; Bukowski R; Parry S; Zhang H; Huang H; Varner MW; Andrews W; Saade G; Sadovsky Y; Reddy UM; Ilekis J;
    Am J Obstet Gynecol; 2016 Mar; 214(3):376.e1-8. PubMed ID: 26692181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind study of effect of 17-hydroxyprogesterone caproate on abortion rate.
    SHEARMAN RP; GARRETT WJ
    Br Med J; 1963 Feb; 1(5326):292-5. PubMed ID: 13977012
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum progesterone, 17 alpha-hydroxyprogesterone, human chorionic gonadotropin, and prolactin in early pregnancy and a case of spontaneous abortion.
    Manganiello PD; Nazian SJ; Ellegood JO; McDonough PG; Mahesh VB
    Fertil Steril; 1981 Jul; 36(1):55-60. PubMed ID: 7250408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies.
    Gyamfi C; Horton AL; Momirova V; Rouse DJ; Caritis SN; Peaceman AM; Sciscione A; Meis PJ; Spong CY; Dombrowski M; Sibai B; Varner MW; Iams JD; Mercer BM; Carpenter MW; Lo J; Ramin SM; O'Sullivan MJ; Miodovnik M; Conway D;
    Am J Obstet Gynecol; 2009 Oct; 201(4):392.e1-5. PubMed ID: 19716543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 17-hydroxyprogesterone caproate for preterm rupture of the membranes: a multicenter, randomized, double-blind, placebo-controlled trial.
    Combs CA; Garite TJ; Maurel K; Abril D; Das A; Clewell W; Heyborne K; How H; Huang W; Lewis D; Lu G; Miller H; Nageotte M; Porreco R; Sheikh A; Tran L;
    Am J Obstet Gynecol; 2015 Sep; 213(3):364.e1-12. PubMed ID: 25979614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In an in-vitro model using human fetal membranes, 17-α hydroxyprogesterone caproate is not an optimal progestogen for inhibition of fetal membrane weakening.
    Kumar D; Moore RM; Mercer BM; Mansour JM; Mesiano S; Schatz F; Lockwood CJ; Moore JJ
    Am J Obstet Gynecol; 2017 Dec; 217(6):695.e1-695.e14. PubMed ID: 29031893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of hydroxyprogesterone caproate to maintain pregnancy in ovariectomised mares.
    McKinnon AO; Tarrida del Marmol Figueroa S; Nobelius AM; Hyland JH; Vasey JR
    Equine Vet J; 1993 Mar; 25(2):158-60. PubMed ID: 8467776
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate.
    Yemini M; Borenstein R; Dreazen E; Apelman Z; Mogilner BM; Kessler I; Lancet M
    Am J Obstet Gynecol; 1985 Mar; 151(5):574-7. PubMed ID: 3976757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The value of serum progesterone and 17-hydroxyprogesterone determination in differential diagnosis of abnormal early pregnancy].
    Römer T; Wodrig W
    Zentralbl Gynakol; 1994; 116(5):276-9. PubMed ID: 8023624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised controlled double-blind clinical trial of 17-hydroxyprogesterone caproate for the prevention of preterm birth in twin gestation (PROGESTWIN): evidence for reduced neonatal morbidity.
    Awwad J; Usta IM; Ghazeeri G; Yacoub N; Succar J; Hayek S; Saasouh W; Nassar AH
    BJOG; 2015 Jan; 122(1):71-9. PubMed ID: 25163819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of 17 alpha-hydroxyprogesterone caproate/oestradiol valerate on the development and outcome of early pregnancies following in vitro fertilization and embryo transfer: a prospective and randomized controlled trial.
    Prietl G; Diedrich K; van der Ven HH; Luckhaus J; Krebs D
    Hum Reprod; 1992 Jun; 7 Suppl 1():1-5. PubMed ID: 1332985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of threatened premature labor by administration of cortisol and 17 alpha-hydroxyprogesterone caproate: a comparison with ritodrine.
    Kauppila A; Hartikainen-Sorri AL; Jänne O; Tuimala R; Järvinen PA
    Am J Obstet Gynecol; 1980 Oct; 138(4):404-8. PubMed ID: 7424996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrinologic events in early pregnancy failure.
    Aspillaga MO; Whittaker PG; Grey CE; Lind T
    Am J Obstet Gynecol; 1983 Dec; 147(8):903-8. PubMed ID: 6650626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inefficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy.
    Hartikainen-Sorri AL; Kauppila A; Tuimala R
    Obstet Gynecol; 1980 Dec; 56(6):692-5. PubMed ID: 7443111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genital and nongenital teratogenesis of prenatal progestogen therapy: the effects of 17 alpha-hydroxyprogesterone caproate on embryonic and fetal development and endochondral ossification in the C57B1/6J mouse.
    Carbone JP; Brent RL
    Am J Obstet Gynecol; 1993 Nov; 169(5):1292-8. PubMed ID: 8238197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 17-Hydroxyprogesterone level as a marker for corpus luteum function in aborters versus nonaborters.
    Check JH; Vaze MM; Epstein R; Wu CH; Quattrocchi J; Vetter B
    Int J Fertil; 1990; 35(2):112-5. PubMed ID: 1970979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical use of 17 alpha-hydroxyprogesterone 17-n-caproate in the prevention of premature labor, and its effect upon fetal salvage.
    EICHNER E
    Ann N Y Acad Sci; 1958 Jul; 71(5):787-93. PubMed ID: 13583833
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical use of 17 alpha-hydroxyprogesterone 17-n-caproate in habitual abortion.
    REIFENSTEIN EC
    Ann N Y Acad Sci; 1958 Jul; 71(5):762-86. PubMed ID: 13583832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.